Skip to main content
Top
Published in: Diabetologia 10/2013

01-10-2013 | Article

Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study

Authors: Alice S. Forster, Angus Forbes, Hiten Dodhia, Clare Connor, Alain Du Chemin, Sobha Sivaprasad, Samantha Mann, Martin C. Gulliford

Published in: Diabetologia | Issue 10/2013

Login to get access

Abstract

Aims/hypothesis

This study evaluated whether repeated non-attendance for diabetic eye screening is associated with the risk of sight-threatening diabetic retinopathy (STDR).

Methods

This was a cohort study of 6,556 residents with diabetes who were invited for screening between 2008 and 2011 in a population-based eye screening programme in inner London and who attended for their first-ever screen in 2008. The proportion of participants with STDR was evaluated in relation to the number of years in which screening was missed.

Results

The proportion of participants who did not attend screening decreased between 2009 and 2011 (annual reduction 1.6% [95% CI 0.9%, 2.3%]). The adjusted relative odds of STDR for 210 participants who did not attend two consecutive years of screening were 3.76 (95% CI 2.14, 6.61; p < 0.001), compared with participants who were screened annually. In 605 participants with mild non-proliferative retinopathy at the first screen, the adjusted relative odds of developing proliferative or moderate to severe non-proliferative retinopathy were 5.72 (95% CI 7.43, 22.83; p = 0.013) for 53 participants who missed two screens.

Conclusions/interpretation

Patients who do not attend diabetic eye screening are at increased risk of developing STDR. Tracing of non-attenders with evidence of established retinopathy should be an important fail-safe procedure.
Literature
1.
go back to reference Resnikoff S, Pascolini D, Etya'ale D et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851PubMed Resnikoff S, Pascolini D, Etya'ale D et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851PubMed
2.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103:1796–1806CrossRef Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103:1796–1806CrossRef
3.
go back to reference Diabetic Retinopathy Study Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic Retinopathy Study report no. 5. Dev Ophthalmol 2:248–261 Diabetic Retinopathy Study Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic Retinopathy Study report no. 5. Dev Ophthalmol 2:248–261
4.
go back to reference English National Diabetic Eye Screening Programme (2011) Annual report 2010/2011. English National Diabetic Eye Screening Programme, Gloucester English National Diabetic Eye Screening Programme (2011) Annual report 2010/2011. English National Diabetic Eye Screening Programme, Gloucester
5.
go back to reference James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 320:1627–1631PubMedCrossRef James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 320:1627–1631PubMedCrossRef
6.
go back to reference Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R (2012) Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr 6:199–202PubMedCrossRef Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R (2012) Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr 6:199–202PubMedCrossRef
7.
go back to reference Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD (2008) Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 31:2131–2135PubMedCrossRef Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD (2008) Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 31:2131–2135PubMedCrossRef
8.
go back to reference Gulliford MC, Dodhia H, Chamley M et al (2010) Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med 27:282–288PubMedCrossRef Gulliford MC, Dodhia H, Chamley M et al (2010) Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med 27:282–288PubMedCrossRef
9.
go back to reference Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRef Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRef
10.
go back to reference Kohner EM, Aldington SJ, Stratton IM et al (1998) United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116:297–303PubMedCrossRef Kohner EM, Aldington SJ, Stratton IM et al (1998) United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116:297–303PubMedCrossRef
11.
go back to reference Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:2335–2342PubMedCrossRef Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:2335–2342PubMedCrossRef
12.
go back to reference Misra A, Bachmann MO, Greenwood RH et al (2009) Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26:1040–1047PubMedCrossRef Misra A, Bachmann MO, Greenwood RH et al (2009) Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26:1040–1047PubMedCrossRef
13.
go back to reference The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
14.
go back to reference Thomas RL, Dunstan F, Luzio SD et al (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344:e874PubMedCrossRef Thomas RL, Dunstan F, Luzio SD et al (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344:e874PubMedCrossRef
15.
go back to reference Younis N, Broadbent DM, Vora JP, Harding SP, The Liverpool Diabetic Eye Study Group (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361:195–200PubMedCrossRef Younis N, Broadbent DM, Vora JP, Harding SP, The Liverpool Diabetic Eye Study Group (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361:195–200PubMedCrossRef
16.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806 Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806
17.
go back to reference NHS Diabetic Eye Screening Programme (2007) National screening programme for diabetic retinopathy workbook. NHS Diabetic Eye Screening Programme NHS Diabetic Eye Screening Programme (2007) National screening programme for diabetic retinopathy workbook. NHS Diabetic Eye Screening Programme
18.
go back to reference Stata Corporation (2012) Stata statistical software. In. Stata Press, College Station, TX, USA Stata Corporation (2012) Stata statistical software. In. Stata Press, College Station, TX, USA
19.
go back to reference Department of Health (2004) GP Bulletin, 31 Department of Health (2004) GP Bulletin, 31
20.
go back to reference Ashworth M, Jenkins M, Burgess K et al (2005) Which general practices have higher list inflation? An exploratory study. Fam Pract 22:529–531PubMedCrossRef Ashworth M, Jenkins M, Burgess K et al (2005) Which general practices have higher list inflation? An exploratory study. Fam Pract 22:529–531PubMedCrossRef
21.
go back to reference Zhang X, Norris SL, Saadine J et al (2007) Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med 33:318–335PubMedCrossRef Zhang X, Norris SL, Saadine J et al (2007) Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med 33:318–335PubMedCrossRef
22.
go back to reference Olafsdottir E, Stefansson E (2007) Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91:1599–1601PubMedCrossRef Olafsdottir E, Stefansson E (2007) Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91:1599–1601PubMedCrossRef
23.
go back to reference Jones CD, Greenwood RH, Misra A, Bachmann MO (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596PubMedCrossRef Jones CD, Greenwood RH, Misra A, Bachmann MO (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596PubMedCrossRef
24.
go back to reference Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319PubMedCrossRef Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319PubMedCrossRef
Metadata
Title
Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study
Authors
Alice S. Forster
Angus Forbes
Hiten Dodhia
Clare Connor
Alain Du Chemin
Sobha Sivaprasad
Samantha Mann
Martin C. Gulliford
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2975-0

Other articles of this Issue 10/2013

Diabetologia 10/2013 Go to the issue